We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Healthcare | 14.47% |
| 3 | Technology | 14.27% |
| 4 | Communication Services | 9.94% |
| 5 | Consumer Staples | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSR
1301
DELISTED
Neustar Inc
NSR
| $590K | ﹤0.01% |
25,095
+1,308
| +5% | +$31.1K |
|
1302
Apple Hospitality REIT
APLE
$3.64B
| $589K | ﹤0.01% |
+31,355
| New | +$587K |
|
1303
HEICO Corp
HEI
$41.8B
| $588K | ﹤0.01% |
21,499
+1,208
| +6% | +$31.2K |
|
1304
Zebra Technologies
ZBRA
$16.1B
| $588K | ﹤0.01% |
11,735
-2,843
| -20% | -$165K |
|
|
AMED
1305
DELISTED
Amedisys
AMED
| $584K | ﹤0.01% |
11,562
-4,372
| -27% | -$221K |
|
1306
EnerSys
ENS
$6.2B
| $583K | ﹤0.01% |
9,805
-104
| -1% | -$6.14K |
|
|
B
1307
DELISTED
Barnes Group Inc.
B
| $583K | ﹤0.01% |
17,603
-983
| -5% | -$33.4K |
|
|
STKL
1308
DELISTED
SunOpta
STKL
| $582K | ﹤0.01% |
138,818
+3,586
| +3% | +$16.6K |
|
|
MBFI
1309
DELISTED
MB Financial Corp
MBFI
| $582K | ﹤0.01% |
16,051
+107
| +0.7% | +$3.69K |
|
1310
Werner Enterprises
WERN
$2.15B
| $581K | ﹤0.01% |
25,277
+5,054
| +25% | +$126K |
|
1311
Integra LifeSciences
IART
$1.25B
| $580K | ﹤0.01% |
14,536
-1,024
| -7% | -$36.8K |
|
1312
Liberty Latin America Class C
LILAK
$1.71B
| $580K | ﹤0.01% |
+20,847
| New | +$692K |
|
|
GCP
1313
DELISTED
GCP Applied Technologies Inc.
GCP
| $579K | ﹤0.01% |
+22,234
| New | +$522K |
|
1314
Acadia Pharmaceuticals
ACAD
$4.75B
| $578K | ﹤0.01% |
17,797
-1,167
| -6% | -$39.1K |
|
1315
Energizer
ENR
$1.42B
| $578K | ﹤0.01% |
11,230
-8,042
| -42% | -$368K |
|
1316
Teledyne Technologies
TDY
$27.9B
| $578K | ﹤0.01% |
5,839
+702
| +14% | +$66.4K |
|
1317
UFP Industries
UFPI
$4.52B
| $578K | ﹤0.01% |
18,708
+108
| +0.6% | +$3.04K |
|
1318
LXP Industrial Trust
LXP
$3.59B
| $574K | ﹤0.01% |
11,362
+480
| +4% | +$22.2K |
|
|
AD
1319
Array Digital Infrastructure
AD
$3.28B
| $573K | ﹤0.01% |
14,602
-444
| -3% | -$17.7K |
|
1320
Bausch Health
BHC
$2.13B
| $570K | ﹤0.01% |
28,291
-7,301
| -21% | -$207K |
|
|
LPNT
1321
DELISTED
LifePoint Health, Inc.
LPNT
| $567K | ﹤0.01% |
8,674
+1,085
| +14% | +$73.8K |
|
1322
EastGroup Properties
EGP
$10.6B
| $566K | ﹤0.01% |
8,214
+18
| +0.2% | +$1.14K |
|
1323
Celestica
CLS
$40.8B
| $563K | ﹤0.01% |
60,539
-41,817
| -41% | -$436K |
|
1324
Sensata Technologies
ST
$6.1B
| $563K | ﹤0.01% |
16,125
+6,921
| +75% | +$253K |
|
1325
The GEO Group
GEO
$4.14B
| $562K | ﹤0.01% |
24,666
-2,160
| -8% | -$47.6K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.